Back

Combination therapy with renin-angiotensin system inhibitors and statins is associated with reduced incidence of new-onset atrial fibrillation in hypertensive patients

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hypertension and Atrial Fibrillation Target Organ Damage/Left Ventricular Hypertrophy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Takeshi Horio

Ishikiriseiki Hospital, Higashi-Osaka (Japan)

3 More presentations in this session

Presentation thumbnail
Fatal attraction: hypertension and atrial fibrillation - Current knowledge
Professor A. Manolis (Athens, GR)
Slides Video
Presentation thumbnail
Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study
Doctor E. Sharashova (Tromso, NO)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of edoxaban vs warfarin stratified by achieved blood pressure in 19,754 patients with hypertension in ENGAGE AF-TIMI 48
Professor S. Park (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension and Atrial Fibrillation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
How does imaging guide management in my patients with hypertension?
thumbnail
Congress Presentation
Arterial hypertension
thumbnail
Congress Presentation
Left ventricular hypertrophy, wall thickness, and histological myocyte alteration in end-stage heart failure: a call for a standard definition

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources